Oncopeptides announces successful price negotiations for Pepaxti in Germany
Oncopeptides announces successful price negotiations for Pepaxti in Germany
"
Several factors decide the reimbursed price of a new drug, including the innovation the drug adds and the existence of existing treatments (comparators) for the same condition in the same line of treatment. The negotiated price is valid for Pepaxti in its current indication.
Investor Q&A
How are price negotiations in Germany conducted?
After a drug receives marketing approval from the
Are you able to communicate the price?
The reimbursed price will be made public later this fall by publication in
What price have you used this far when selling in Germany ?
We have a current list price of €10,900 per month (€5,450 per vial), however we have accrued for a discounted price in line with the now confirmed price since
How can the negotiated price in Germany affect price negotiations in other EU markets?
The price of a drug negotiated in
How would this affect the price of Pepaxti in potential earlier lines of treatment?
Pepaxti is currently approved as a treatment for multiple myeloma in later lines of treatment, where there currently is a high unmet need. Should
Attachments
Disclaimer


Cigna pays $150,000 penalty to settle Virginia complaint
Experts say Gov. Tate Reeves' plan will help hospitals, but not uninsured Mississippians
Advisor News
- The Gen Z money paradox
- NAIFA applauds final SECURE 2.0 regulations
- What will Democrats in Congress do about healthcare and retirement?
- Election results cloud retirement legislation outlook, experts say
- Planning for the missing chapter
More Advisor NewsAnnuity News
- ‘It’s really shocking:’ Regulators scrutinize assets backing annuity sellers
- Jackson Launches Direct-to-Consumer Annuity Offering
- Global Atlantic launches ForeIncome Flex
- Athene CEO criticizes offshore reinsurance, risk-taking by competitors
- DOL, trade groups, state AGs file briefs supporting Alcoa in PRT lawsuit
More Annuity NewsHealth/Employee Benefits News
- Obamacare: The Cure That Made Insurance Sick
- Health insurers leave Ohio marketplace
- Blue Cross flags $5.5B in added medical coding costs at NAIC meeting
- MEDICAL FRAILTY AND MEDICAID WORK REQUIREMENTS: CHALLENGES FOR PEOPLE WITH MENTAL HEALTH CONDITIONS
- HOW NEW PHYSICIANS CAN AVOID PAYMENT PITFALLS IN MEDICARE AND MEDICAID
More Health/Employee Benefits NewsLife Insurance News
- Best’s Commentary: Shanghai Cross-Border Investment Pilot Unlocks Overseas Growth Potential of China Non-Life Companies
- Military Briefs: November 19-25
- California’s new solvency rules: What should life insurance advisors watch?
- Navigating delayed death certificates: A guide for life insurance advisors
- Jackson Launches Direct-to-Consumer Annuity Offering
More Life Insurance News